What laboratory findings are consistent with Severe Combined Immunodeficiency (SCID)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Laboratory Findings Consistent with Severe Combined Immunodeficiency (SCID)

The primary laboratory findings consistent with SCID include profound T-cell lymphopenia (CD3+ T cells <300/μL), absent or very low T-cell receptor excision circles (TRECs), and severely impaired T-cell function with poor proliferation to mitogens. 1, 2

Core Immunologic Abnormalities

  • T-cell abnormalities: Severe T-cell lymphopenia with CD3+ T-cell counts typically <300/μL, which is the hallmark laboratory finding in SCID 2
  • Lymphopenia: Absolute lymphocyte counts <2,500/μL are present in approximately 63% of SCID patients 3
  • T-cell function: Profoundly reduced proliferation in response to mitogens such as phytohemagglutinin (PHA) 1, 4
  • TRECs: Very low or absent T-cell receptor excision circles, which are used in newborn screening programs to identify SCID 5, 1
  • Naïve T cells: Less than 20% of CD4+ T cells expressing naïve markers (CD45RA+) 2

Immunophenotypic Patterns

SCID can be classified based on the presence or absence of T, B, and NK cells, which helps determine the underlying genetic defect:

  • T-B-NK-: Seen in adenosine deaminase (ADA) deficiency, affecting all lymphocyte lineages 1
  • T-B+NK-: Common in X-linked SCID (IL2RG mutations) and JAK3 deficiency 1, 6
  • T-B-NK+: Characteristic of RAG1/2 deficiencies and other defects in V(D)J recombination 1
  • T-B+NK+: Observed in IL-7 receptor deficiency and CD3 complex defects 1

Immunoglobulin Abnormalities

  • Hypogammaglobulinemia: Low or absent IgA and IgM levels 1
  • Variable IgG levels: May be normal early in life due to maternal transfer across the placenta 1
  • Poor specific antibody production: Impaired responses to vaccines or natural infections 5

Additional Laboratory Findings

  • Maternal T-cell engraftment: Presence of maternal T cells in the infant's circulation, which can be detected by HLA typing or short tandem repeat analysis 2
  • Oligoclonal T cells: Limited T-cell receptor diversity in patients with leaky/atypical SCID 2
  • Eosinophilia and elevated IgE: Particularly in Omenn syndrome, a variant of SCID 2

Diagnostic Approach

  • Complete blood count: Initial screening should include absolute lymphocyte count to identify lymphopenia 1, 3
  • Flow cytometry: Essential to enumerate T, B, and NK cell numbers and determine the immunophenotypic pattern 1
  • T-cell function tests: Lymphocyte proliferation assays in response to mitogens (PHA) 4
  • Genetic testing: Molecular diagnosis to identify the specific gene defect 3

Clinical Implications

  • A suspicion of SCID should be considered an urgent clinical condition requiring immediate intervention 5
  • Early diagnosis through laboratory testing is critical as outcomes are significantly better when treatment (HSCT) is initiated before 3.5 months of age 5
  • Patients with typical SCID have <500 CD3+ T cells/μL, while those with leaky/atypical SCID have reduced but detectable T cells with impaired function 4, 2

Common Pitfalls

  • Some forms of combined immunodeficiency may have normal TREC levels and would not be detected by newborn screening programs (e.g., FOXP3, CD40L, and IL10RA mutations) 4
  • Maternal T-cell engraftment can mask the diagnosis by providing apparently normal T-cell counts 2
  • Premature infants may have transiently low TREC counts that increase over time, potentially leading to false-positive screening results 5

References

Guideline

Cell Types Affected in Severe Combined Immunodeficiency (SCID)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Defining combined immunodeficiency.

The Journal of allergy and clinical immunology, 2012

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Severe combined immunodeficiency with B-lymphocytes (T-B+SCID): report of two cases.

Zhonghua Minguo xiao er ke yi xue hui za zhi [Journal]. Zhonghua Minguo xiao er ke yi xue hui, 1998

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.